Showing results (51-60 of 149) with videos related to

Sort By:
Pageof 15
Expert Review of Hematology|March 6, 2023
Assessing eligibility for treatment in acute myeloid leukemia in 2023Adriano Venditti, Roberto Cairoli, Morena Caira, et al.
Haematologica|November 13, 2008
Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow TransplantationEnrica Morra, Giovanni Barosi, Alberto Bosi, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|May 24, 2003
Complete remission induced by G-CSF in a patient with acute myeloid leukemia with t(8;21)(q22;q22)Felicetto Ferrara, Ettore Mariano Schiavone, Salvatore Palmieri, et al.
Expert Review of Hematology|September 3, 2013
Treatment of elderly patients with chronic lymphocytic leukemia: an unmet cinical needStefano Molica, Maura Brugiatelli, Fortunato Morabito, et al.
Cancer|May 1, 2007
Efficacy and safety of bortezomib in patients with plasma cell leukemiaPellegrino Musto, Fausto Rossini, Francesca Gay, et al.
Cancer Cell|February 18, 2010
PML-RARalpha/RXR Alters the Epigenetic Landscape in Acute Promyelocytic LeukemiaJoost H A Martens, Arie B Brinkman, Femke Simmer, et al.
Annals of Hematology|March 16, 2006
Vinorelbine plus intermediate dose cyclophosphamide is an effective and safe regimen for the mobilization of peripheral blood stem cells in patients with multiple myelomaMario Annunziata, Maria Celentano, Barbara Pocali, et al.
European Journal of Haematology|June 13, 2003
Fludarabine plus cyclophosphamide for the treatment of advanced chronic lymphocytic leukemiaEttore Mariano Schiavone, Mariacarla De Simone, Salvatore Palmieri, et al.
Hematological Oncology|March 17, 2007
Age has no influence on mobilization of peripheral blood stem cells in acute myeloid leukemiaFelicetto Ferrara, Assunta Viola, Carolina Copia, et al.
European Journal of Haematology|October 18, 2006
An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemiaAssunta Viola, Claudio Falco, Rossella D'Elia, et al.
Pageof 15